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Abst rac t
Introduction: Due to the rising incidence of cutaneous melanoma there is a great need for the development of 
new diagnostic techniques as well as the improvement of those that are already well known, such as dermoscopy. 
Since early detection and a proper technique for excising the tumor are crucial for patients’ survival, early staging 
of the tumor is very important.
Aim: To investigate whether there is a significant difference between the presence of selected dermoscopic features 
compared to the location on the skin and pathology results: Breslow’s depth, mitotic index and ulceration.
Material and methods: We examined videodermoscopic images of cutaneous melanomas in 81 patients and com-
pared their features with the histological results such as Breslow’s depth, mitotic index and ulceration. In the study, 
we divided and compared the tumors in groups: in situ and invasive, ≤ 1.0 mm and > 1.0 mm thick on the Breslow 
scale.
Results: In the study we observed statistically significantly higher prevalence of pseudopods (30.5%) and multicom-
ponent pattern (69.5%) in invasive melanomas in comparison to in situ melanomas (9.1% and 36.4% respectively). 
White regression structures were more commonly described in invasive melanomas thicker than 1.0 mm on Bre-
slow’s scale. Atypical blood vessels and nodules were more specific to invasive melanomas with ulcerations and 
mitotic index ≥ 1. The atypical pigment network was more specific for thin invasive melanomas.
Conclusions: Presence of pseudopods, a multicomponent pattern, white regression structures, atypical blood vessels 
and nodules on dermoscopy suggest invasive (high stage) melanoma.
Key words: dermoscopy, melanoma, cutaneous malignant melanoma.
Introduction
Due to the rising incidence of cutaneous melanoma 
in Europe and increasing social awareness, the number of 
patients who report to dermatologists in order to assess 
their skin changes is growing rapidly [1, 2]. For examining 
melanocytic skin lesions, dermoscopes have currently be-
come the first-line diagnostic tools since they allow the 
in vivo examination of structures in the epidermis and 
superficial dermis which are not accessible for naked-eye 
examination [3–5].
The first detailed description of the microscopic as-
sessment of the surface of the skin was presented by 
Saphier, who also introduced the term dermatoscopy for 
the first time in the 1920s. It was not until 1951 in the 
USA that Goldman first described the dermoscopic image 
of melanocytic nevi. The rapid development of dermos-
copy as a method of assessing melanocytic changes in 
the skin occurred in the 1980s, mainly due to the work of 
Soyer and Pehamberger [6]. The next step was the intro-
duction of videodermoscopy as a technique for recording 
and comparing images of selected skin lesions, enabling 
dermatologists to diagnose early stages of cutaneous 
melanoma [7].
In modern dermatological practice, dermoscopy (epi-
luminescent microscopy) is considered a non-invasive, 
easily reproducible and inexpensive method of the in 
vivo assessment of structures and colors within the 
epidermis and superficial dermis. It allows examination 
using 10–20× magnification – in traditional handheld 
dermoscopes – and 10–200×magnification in videoder-
moscopes [8]. Dermoscopy enables the clinician to ex-
amine plural diagnostic features in different skin lesions, 
which are normally impossible to detect with the naked 
eye. As a vastly researched technique it is known to have 
a high specificity of ≈ 65–90% and sensitivity evaluated 
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as ≈ 65–90% [9–11] if performed by a well-experienced 
clinician [7, 12].
Breslow’s depth – described in the 1970s – is a meth-
od that allows the pathologist to assess the stage of 
melanoma by measuring the depth of infiltration in mil-
limeters [13]. At first staging the cutoff was applied for 
Breslow’s depth of 0.76 mm, later updated by the Ameri-
can Joint Committee on Cancer to 1.0 mm (or < 1.0 mm 
when ulceration is present) [13, 14].
Advanced metastatic melanoma is still considered 
incurable in most cases, whereas early cutaneous mela-
nomas are curable by means of surgical excision. Accord-
ing to guidelines in patients with cutaneous melanomas 
stage ≤ pT1a, surgical excision within the range 0.5–1 cm 
[15, 16] is considered curative. In patients with > pT1a 
melanomas, usually sentinel lymph node biopsy and of-
ten subsequent surgery remain unavoidable [15–17]. Even 
though there are plural emerging therapies introduced in 
the treatment of metastatic melanomas, it still remains 
the case that the more advanced the disease the worse 
the prognosis (overall survival) for the patients [18–20]. 
This is why an early, accurate diagnosis is crucial for posi-
tive outcomes. Nowadays, despite the emergence of di-
agnostic tools such as reflectance confocal microscopy 
[21–24], and optical coherence tomography [25], which 
have been described as being more specific and sensitive 
than dermoscopy [24, 26, 27], their accessibility is still 
limited, and dermoscopy remains a first-line diagnostic 
tool for dermatologists [25, 28].
Aim
In the study, the goal was to decide whether there is 
a significant difference between the presence or absence 
of each of the dermoscopic features listed in Table 1 [29–
31], compared to the location on the skin and pathology 
results: Breslow’s depth, mitotic index and ulceration. 
Material and methods
In our study, we retrospectively evaluated videoder-
moscopic images of histopathologically confirmed mela-
nomas in 81 patients that were diagnosed and examined 
at the Dermatology Department, Jagiellonian University 
Medical College in Krakow, Poland. The dermoscopic im-
ages were acquired using videodermoscopes (Fotofinder, 
TeachScreen GmbH, Bad Birnbach, Germany). For every 
lesion a set of at least 3 images was acquired. Entire le-
sions were photographed using 20× magnification. In 
addition, local features of tumors were photographed 
using maximum 120× magnification. The image data 
were collected between 2013 and 2017. The evaluation 
was conducted by two dermatologists with a minimum 
of 6 years’ experience in general dermatology and der-
moscopy. For the purpose of blinding the images were 
anonymized. For all the evaluated tumors, the patients’ 
data were collected, including: age (at the time of diagno-
sis), sex, location of the primary tumor, Breslow’s depth, 
the histological subtype of melanoma, mitotic index and 
information on the presence/absence of ulceration.
The examining dermatologists evaluated the lesions 
assessing the presence or absence of the following der-
moscopic features: white regression structures; pep-
pering; blue-white veil; atypical blood vessels/atypical 
vascular structures; atypical pigment network; atypical 
dots and globules; irregular streaks; a multicomponent 
(complex) pattern; pseudopods and nodules. The defini-
tions of listed structures are available in Table 1.
Table 1. Definitions of dermoscopic structures evaluated in the study [29–31]
Pigment network Light-to-dark brown fishnet-like pattern appearing on pathology melanocytes at dermo-epidermal 
junction (melanocytes forming lines of network with dermal papillae forming “holes”)
Atypical pigment network Atypical black/gray/brown network with thickened mesh and plural irregularities
Atypical dots and globules Asymmetrically distributed brown/ black and gray dots (≤ 0.1 mm), round and oval structures 
(globules) representing the accumulation of melanin (most commonly in melanocytes but sometimes 
also in melanophages) – most commonly in melanocytic “nests”
Blue-white veil Unstructured areas in blue-grayish/blue-whiteish color; with ground glass appearance. Represents 
compact aggregation of melanocytes with concomitant orthokeratosis
Streaks Atypical, irregular linear structures that are not connected to pigment network
White regression structures Whiteish depigmentation (lighter than adjacent skin); scar-like structures. Represent regression 
structures and fibrosis in advanced melanomas
Peppering Represent regression structures with the presence of melanophages forming a dermoscopic image 
of black-grayish dots
Nodules Elevated structures within the lesion (corresponding to large blue, black and brown clods)
Atypical blood vessels/
atypical vascular structures
Pinkish erythema in regression structures/dotted and irregular linear blood vessels
Multicomponent pattern ≥ 3 areas representing different dermoscopic features in a single lesion. Usually combined with 
asymmetry in malignant lesions
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In the study, we evaluated the association between the 
presence of the dermoscopic structures (listed in Table 1) 
and histopathological stage of melanoma – by dividing 
tumors into: in situ, thin invasive tumors (using cutoff at 
≤ 1.0 mm) and thick invasive tumors (cutoff at > 1.0 mm). 
We also assessed the predictors in accordance with the 
mitotic index (0 or ≥ 1) and presence of ulceration. 
Dermoscopic images of acral, nail apparatus, spitzoid 
and amelanotic melanomas were excluded due to differ-
ences in the dermoscopic picture of such tumors. 
Results
The group of patients consisted of 44 men and 37 
women aged (at the day of diagnosis) between 26 and 
97 with the average being 61.4 and the median being 63.
Regarding the distribution of the lesions, 14 (17.28%) 
were found on the head, 37 (45.68%) on the trunk, 16 
(19.75%) on the upper limbs and 14 (17.28%) on the lower 
limbs.
Twenty-two (27.16%) of 81 melanomas were in situ, 
and 59 (72.84%) were invasive. On pathology examina-
Table 2. Frequency of various dermoscopic features depending on the location on the skin (head, trunk, upper and 
lower limbs)
Parameter Tumor location
Head Trunk Upper limbs Lower limbs Total c2; 
p-value




Absent 2 14.29 8 21.62 1 6.25 4 28.57 15 18.52
Present 12 85.71 29 78.38 15 93.75 10 71.43 66 81.48
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Peppering Absent 3 21.43 19 51.35 9 56.25 9 64.29 40 49.38 5.98; 
0.113Present 11 78.57 18 48.65 7 43.75 5 35.71 41 50.62
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Blue-white veil Absent 5 35.71 16 43.24 5 31.25 6 42.86 32 39.51 0.82; 
0.844Present 9 64.29 21 56.76 11 68.75 8 57.14 49 60.49
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Atypical blood 
vessels
Absent 10 71.43 20 54.05 7 43.75 7 50.00 44 54.32 2.48; 
0.479Present 4 28.57 17 45.95 9 56.25 7 50.00 37 45.68




Absent 8 57.14 8 21.62 8 50.00 3 21.43 27 33.33 8.75; 
0.033Present 6 42.86 29 78.38 8 50.00 11 78.57 54 66.67
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Irregular dots 
and globules 
Absent 7 50.00 7 18.92 5 31.25 5 35.71 24 29.63 5.09; 
0.165Present 7 50.00 30 81.08 11 68.75 9 64.29 57 70.37
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Irregular streaks Absent 8 57.14 18 48.65 6 37.50 4 28.57 36 44.44 2.92; 
0.404Present 6 42.86 19 51.35 10 62.50 10 71.43 45 55.56
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Multicomponent 
pattern
Absent 7 50.00 11 29.73 10 62.50 4 28.57 32 39.51 6.36; 
0.095Present 7 50.00 26 70.27 6 37.50 10 71.43 49 60.49
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Pseudopods Absent 14 100.00 28 75.68 12 75.00 7 50.00 61 75.31 9.42; 
0.024Present 0 0 9 24.32 4 25.00 7 50.00 20 24.69
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
Nodules Absent 12 85.71 23 62.16 12 75.00 11 78.57 58 71.60 3.42; 
0.332Present 2 14.29 14 37.84 4 25.00 3 21.43 23 28.40
Total 14 100.00 37 100.00 16 100.00 14 100.00 81 100.00
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tion in 6 (7.5%) tumors ulceration was detected and in 23 
(28.4%) lesions the mitotic index was ≥ 1. 
Comparison of the prevalence of the listed dermoscop-
ic features (Table 1) between male and female patients 
showed a statistically significantly higher prevalence of 
atypical blood vessels and a multicomponent pattern in 
female patients (62.2 and 73% respectively; p < 0.005).
Assessing the relation between evaluated dermo-
scopic structures and different locations of primary tu-
mors (head, trunk, lower limbs, and upper limbs) (Table 2) 
we found that pseudopods were most commonly pres-
ent on the lower limbs (50%), less commonly on the 
trunk and upper limbs (24.32% and 25% respectively; p 
= 0.024). An atypical network was described in 66.67% of 
all tumors, ranging between 78.57% and 78.38% on the 
lower limbs and trunk, and 42.86% and 50% on the head 
and upper limbs (Figure 1). 
In situ melanomas showed a significantly lower fre-
quency of pseudopods and multicomponent pattern 
(9.1% and 36.4%) in comparison with invasive tumors – 
with 30.5% and 69.5% positive for pseudopods and mul-
ticomponent pattern (Table 3).
Tumors thicker than 1.0 mm showed a higher preva-
lence of white regression structures with 22.7% sensi-
tivity, though 100% specificity. An atypical network was 
observed in 46.7% of tumors > 1.0 mm thick and in 71.2% 
of thinner tumors, though the difference was not statis-
tically significant (Figure 2). In 60% of melanomas > 1.0 
mm thick and 21.2% of melanomas ≤ 1.0 mm nodules 
were described in dermoscopy. 
The study also showed a negative correlation be-
tween the positive mitotic index and an atypical network, 
and positive correlation between MI ≥ 1 and nodules as 
well as a positive correlation for presence of ulceration 
and atypical blood vessels/vascular structures and nod-
ules on dermoscopy.
Discussion
The last three decades have brought rapid develop-
ment of diagnostic tools in dermato-oncology. Due to 
Table 3. Frequency of various dermoscopic features of in situ and invasive melanomas
Variable Invasive melanoma
n (%)
Melanoma in situ 
n (%)
P-value OR (95% CI) Sensitivity Specificity
White regression structures 48 (81.4) 18 (81.8) 0.962 1.03 (0.29–3.66)
Peppering 28 (47.5) 13 (59.1) 0.352 1.60 (0.59–4.31)
Blue-white veil 37 (62.7) 12 (54.5) 0.504 0.71 (0.26–1.92)
Atypical blood vessels 27 (45.8) 10 (45.5) 0.980 0.99 (0.37–2.64)
Atypical pigment network 39 (66.1) 15 (68.2) 0.860 1.10 (0.39–3.13)
Irregular dots and globules 45 (76.3) 12 (54.5) 0.057 0.37 (0.13–1.05)
Irregular streaks 35 (59.3) 10 (45.5) 0.264 0.57 (0.21–1.53)
Multicomponent pattern 41 (69.5) 8 (36.4) 0.007 0.25 (0.09–0.70) 83.7 43.8
Pseudopods 18 (30.5) 2 (9.1) 0.047 0.23 (0.05–1.08) 90.0 32.8
Nodules 20 (33.9) 3 (13.6) 0.072 0.31 (0.08–1.17)
Figure 1. Atypical network and pseudopods in invasive 
melanoma of the lower limb
Figure 2. Atypical network (blue dots), white regression 
structures and atypical blood vessels (red dots) in invasive 
melanoma of the trunk
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their accessibility, dermoscopy and videodermoscopy are 
the most commonly used diagnostic techniques in the 
early diagnosis of cutaneous melanoma [8, 32]. In order to 
standardize dermoscopic examinations specific diagnostic 
features, as well as criteria, have been described. The most 
popular algorithms applied in the dermoscopic diagnosis 
of melanoma are: pattern analysis [6], ABCD criteria [9, 33, 
34], and the 7-point checklist [3, 35]. Knowing the listed cri-
teria allows the early detection of cutaneous melanomas 
by an experienced dermoscopist in contrast to naked-eye 
examination. It would be extremely useful if it could also 
help clinicians to determine the tumor stage or Breslow’s 
depth, in order to simplify the planning of excisions and 
possible sentinel lymph node biopsies.
In previous studies, there have been a few attempts 
to examine the possible correlations between the pres-








P-value2 OR (95% CI) Cutpoint Sensitivity Specificity
White regression structures 0.35 ±0.30 1.10 ±2.64 0.255 2.41 (0.74–7.87) – – –
Peppering 0.80 ±0.93 1.12 ±3.26 0.095 1.06 (0.86–1.31) – – –
Blue-white veil 0.77 ±1.42 1.08 ±2.88 0.335 1.07 (0.85–1.35) – – –
Atypical blood vessels/atypical 
vascular structures
0.62 ±0.88 1.37 ±3.40 0.457 1.25 (0.85–1.82) – – –
Atypical pigment network 1.86 ±3.96 0.51 ±0.64 0.040 0.55 (0.32–0.95) 0.375 70.3 59.3
Atypical dots and globules 0.85 ±1.62 1.01 ±2.68 0.399 1.03 (0.82–1.29) – – –
Streaks 1.47 ±3.50 0.55 ±0.60 0.821 0.69 (0.43–1.12) – – –
Multicomponent pattern 0.77 ±1.45 1.08 ±2.87 0.176 1.07 (0.85–1.35) – – –
Pseudopods 1.11 ±2.75 0.49 ±0.34 0.921 0.68 (0.34–1.38) – – –
Nodules 0.57 ±1.03 1.93 ±4.11 0.030 1.52 (0.96–2.43) 0.375 60.9 53.4
1Traits – dermoscopy features: white regression structures, peppering, blue-white veil, atypical blood vessels/atypical vascular structures, atypical pigment net-
work, atypical dots and globules, streaks, multicomponent pattern, pseudopods, nodules. P-value – statisticaly significant if < 0.05.
Table 4. Frequency of dermoscopic features in melanomas ≤ 1.0 mm and > 1.0 mm on Breslow’s depth
Variable Breslow ≤ 1.0 mm
n (%)
Breslow > 1.0 mm
n (%)
P-value OR (95% CI) Sensitivity Specificity
White regression structures 51 (77.3) 15 (100.0) 0.041 – 22.7 100.0
Peppering 35 (53.0) 6 (40.0) 0.362 0.59 (0.19–1.85) – –
Blue-white veil 38 (57.6) 11 (73.3) 0.260 2.03 (0.58–7.03) – –
Atypical blood vessels/atypical 
vascular structures
28 (42.4) 9 (60.0) 0.217 2.04 (0.65–6.38) – –
Atypical pigment network 47 (71.2) 7 (46.7) 0.069 0.35 (0.11–1.11) – –
Atypical dots and globules 45 (68.2) 12 (80.0) 0.366 1.87 (0.48–7.32) – –
Streaks 40 (60.6) 5 (33.3) 0.055 0.33 (0.10–1.06) – –
Multicomponent pattern 39 (59.1) 10 (66.7) 0.588 1.38 (0.43–4.51) – –
Pseudopods 19 (28.8) 1 (6.7) 0.073 0.18 (0.02–1.44) – –
Nodules 14 (21.2) 9 (60.0) 0.003 5.57 (1.70–18.31) 39.1 89.7
ence of distinct dermoscopic features and tumor thick-
ness, though the results are contradictory. 
In a study on 123 melanomas (including only tumors 
with a Breslow’s depth of > 0.75), González-Álvarez 
et al. observed a correlation of dermoscopic ulcerations 
and blotches with positive sentinel lymph node biopsy 
results and the presence of an atypical pigment network 
with negative sentinel lymph node biopsy results [36]. 
Pizzichetta et al. examined and compared dermoscopic 
images of in situ melanomas and invasive melanomas 
(subdivided into two groups ≤ 0.75 mm and > 0.75 mm), 
finding a lower prevalence of atypical pigment network 
and pseudopods in thick invasive melanomas (> 0.75 mm) 
in comparison with in situ melanomas, as well as greater 
relative numbers of pseudopods, brown globules, gray-
blue areas, and depigmentation in in situ lesions com-
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pared with invasive melanomas with a Breslow’s depth 
of ≤ 0.75 mm. On the other hand, Menzies et al., re-
searching the morphologic criteria of pseudopods in 80 
melanomas (62 invasive and 18 in situ) and 159 randomly 
selected pigmented nonmelanomas, observed higher 
prevalence of the structures in invasive melanomas in 
comparison to in situ tumors. Pseudopods retained 97% 
specificity, though only 23% sensitivity [37]. Emiroglu et 
al., researching only trunk melanomas (71 cases), found 
no correlation between dermoscopic image and Bres-
low’s depth [38].
In our study using univariate regression analysis, we 
compared the prevalence of the listed dermoscopic fea-
tures (Table 1) between male and female patients, and 
found a significantly higher prevalence of atypical blood 
vessels and a multicomponent pattern in female patients 
(62.2% and 73% respectively; p < 0.005). The analysis 
showed no significant differences in different age groups. 
The c2 analysis was performed to assess the relation 
between evaluated dermoscopic structures and different 
locations of primary tumors (head, trunk, lower limbs, 
and upper limbs) (Table 2). There were no significant dif-
ferences in the presence of regression, peppering, atypi-
cal blood vessels, atypical dots and globules, multicom-
ponent pattern or nodules. Pseudopods were present in 
24.69% of all evaluated tumors; most commonly they 
were observed on the lower limbs (50%), less commonly 
on the trunk and upper limbs (24.32% and 25% respec-
tively; p = 0.024). An atypical network was described 
in 66.67% of all tumors, ranging between 78.57% and 
78.38% on the lower limbs and trunk, and 42.86% and 
50% on the head and upper limbs. 
In order to analyze possible relationships between 
the presence of the listed dermoscopic features and 
histopathologic stage of melanomas, the Mann-Whitey 
U test and Student’s t test were used. In situ melanomas 
were evaluated separately as well as tumors presenting 
Breslow’s depth ≤ 1 mm and > 1 mm to check for differ-
ences in frequency of appearance of distinct dermoscopic 
structures. No statistically significant differences regard-
ing the prevalence of peppering, blue-white veil, atypical 
dots and globules, atypical blood vessels or streaks were 
noted (Table 4). In situ melanomas showed a significant-
ly lower frequency of pseudopods and multicomponent 
pattern (9.1% and 36.4%) in comparison with invasive 
tumors (Figure 3) – with 30.5% and 69.5% positive for 
pseudopods and multicomponent pattern (Table 3).
We have calculated mean Breslow’s depth in mela-
nomas divided into groups depending on the presence/
absence of dermoscopic features. Tumors with a visible 
atypical pigment network had a significantly lower mean 
Breslow’s depth in comparison to melanomas present-
ing no atypical pigment network. Melanomas presenting 
with nodules, on the other hand, had greater Breslow’s 
depth in comparison to tumors presenting no nodules on 
dermoscopy (Table 5).
Taking into account the guidelines updated by the 
American Joint Committee on Cancer (as well as many 
European, including Polish), we compared thick and thin 
melanomas assuming a cutoff point at 1.0 mm Breslow’s 
depth. Tumors thicker than 1.0 mm showed a higher 
prevalence of white regression structures with 22.7% 
sensitivity, though 100% specificity. An atypical net-
work was observed in 46.7% of tumors > 1.0 mm thick 
and in 71.2% of thinner tumors, though the difference 
was not statistically significant. In 60% of melanomas 
> 1.0 mm thick and 21.2% of melanomas ≤ 1.0 mm nod-
ules were described in dermoscopy. Specificity of this 
feature was 89.7% in thick melanomas and sensitivity 
39.1% (p = 0.003; OR = 5.57). 
Considering the fact that the mitotic index was re-
moved from AJCC guidelines in 2018, and replaced with 
ulceration, but is still applied in melanoma staging and 
grading in many European countries [14, 15, 39], we ana-
lyzed the presence of dermoscopic structures in mela-
nomas with a negative mitotic index in comparison to 
melanomas with MI ≥ 1. The Mann-Whitey U test showed 
a negative correlation between the positive mitotic index 
and an atypical network, and a positive correlation be-
tween MI ≥ 1 and nodules.
Controlling for ulceration in pathology, we found 
a positive correlation for atypical blood vessels/vascular 
structures and nodules with low sensitivity (13.9% and 
18.2% respectively; p < 0.05) but high specificity.
Conclusions
The presence of an atypical network may point the 
examining dermatologist towards the diagnosis of thin 
invasive melanoma, whereas pseudopods, a multicompo-
nent pattern, white regression structures, atypical blood 
vessels, and nodules suggest invasive (high stage) mela-
noma. Thus the presence of such dermoscopic structures 
should alert the examining dermatologist. Dermoscopy is 
a very useful method in the early diagnosis of cutaneous 
melanoma, especially in regard to early, non- metastatic 
Figure 3. Multicomponent pattern in invasive melanoma 
of the trunk
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tumors. It may also provide some insight into the meta-
static potential of detected tumors. 
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